ArticlePloS one2014

Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.

Mohammad S Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.